When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Herpes simplex virus infection

Последний просмотренный: 15 Jul 2026
Last updated: 07 Jul 2026

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • dysuria (in women)
  • lymphadenopathy
  • genital ulcer
  • oral ulcer
  • fever
Полная информация

Другие диагностические факторы

  • tingling sensation
  • headache/aseptic meningitis
Полная информация

Факторы риска

  • HIV infection (risk factor for clinical disease)
  • use of immunosuppressive drugs (risk factor for clinical disease)
  • female sex (risk factor for seropositivity)
  • black race (risk factor for seropositivity)
  • increasing age (risk factor for seropositivity)
  • high-risk sexual behavior (risk factor for seropositivity)
  • lack of condom use (risk factor for seropositivity)
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • HSV polymerase chain reaction (PCR)
  • viral culture
Полная информация

Исследования, проведение которых нужно рассмотреть

  • Glycoprotein G-based type-specific serology (gG1 and gG2)
Полная информация

Алгоритм лечения

Острый

CNS involvement: encephalitis or meningitis

disseminated visceral involvement: esophagitis, pneumonitis, or hepatitis

genital disease: first episode, immunocompetent, nonpregnant

genital disease: first episode, immunocompromised, nonpregnant

genital disease: recurrent episode, immunocompetent, nonpregnant

genital disease: recurrent episode, immunocompromised, nonpregnant

genital disease: primary or first-episode, pregnant

genital disease: recurrent episode, pregnant

oral disease: first episode, immunocompetent

oral disease: first episode, immunocompromised

oral disease: recurrent episode, immunocompetent

oral disease: recurrent episode, immunocompromised

ПРОДОЛЖЕНИЕ

genital disease: sexually active or frequent severe recurrences, immunocompetent, nonpregnant

genital disease: sexually active or frequent severe recurrences, immunocompromised, nonpregnant

genital disease: pregnant

oral disease: frequent severe recurrences, immunocompetent

oral disease: frequent severe recurrences, immunocompromised

Составители

Авторы

Benjamin D. Lorenz, MD

Assistant Professor

Division of Hospital Medicine

MedStar Georgetown University Hospital

Washington, DC

Раскрытие информации

BDL declares that he has no competing interests. Since completing the 2024 review, BDL has become an employee of Moderna and has resigned as a contributor.

Выражение благодарностей

Dr Benjamin D. Lorenz would like to gratefully acknowledge Dr Christine Johnson and Dr Anna Wald, previous contributors to this topic.

Раскрытие информации

CJ reports funding from AiCuris; grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies; and royalties from Up To Date. AW reports grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies. AW receives royalties from Up To Date. AW is an NIH grant recipient (NIH AI30731 and AI071113) and a consultant for Aicuris, Eisai, and Amgen.

Рецензенты

Giuseppe Pizzo, DDS

Associate Professor

Department of Surgical, Oncological and Oral Sciences

School of Dentistry

University of Palermo

Palermo

Italy

Раскрытие информации

GP declares that he has no competing interests.

Paul Adamson, MD, MPH

Assistant Clinical Professor of Medicine

David Geffen School of Medicine

University of California, Los Angeles

Los Angeles, CA

Раскрытие информации

PA declares that he has no competing interests.

Nicholas Van Wagoner, MD, PhD

Associate Professor of Medicine

University of Alabama

Birmingham, AL

Раскрытие информации

NVW declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Centers for Disease Control and Prevention. Morbidity and mortality weekly report: sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Полный текст

Patel R, Kennedy OJ, Clarke E, et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS. 2017 Dec;28(14):1366-79.Полный текст  Аннотация

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 220: management of genital herpes in pregnancy. May 2020 [internet publication].Полный текст

British Association for Sexual Health & HIV; Royal College of Obstetricians and Gynaecologists. Management of genital herpes in pregnancy. Oct 2014 [internet publication].Полный текст

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности